Jane Street
RLAY icon

Jane Street’s Relay Therapeutics RLAY Stock Holding History

Jane Street’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Buy
200,200
+183,600
+1,106% +$2.67M ﹤0.01% 4151
2026
Q1 		$165K Sell
16,600
-2,100
-11% -$18.8K ﹤0.01% 10306
2025
Q4 		$158K Sell
18,700
-7,700
-29% -$54.9K ﹤0.01% 9891
2025
Q3 		$138K Buy
+26,400
New +$101K ﹤0.01% 9943
2023
Q3 		– Sell
-12,600
Closed -$158K – 9263
2023
Q2 		$158K Buy
+12,600
New +$157K ﹤0.01% 7787
2023
Q1 		– Sell
-12,200
Closed -$182K – 9778
2022
Q4 		$182K Sell
12,200
-23,400
-66% -$448K ﹤0.01% 7736
2022
Q3 		$796K Buy
+35,600
New +$781K ﹤0.01% 5847
2021
Q4 		– Sell
-49,600
Closed -$1.56M – 10704
2021
Q3 		$1.56M Buy
+49,600
New +$1.67M ﹤0.01% 4994

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Jane Street's RLAY Position: Q2 2026 in Review

Jane Street sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 423,536 shares — an estimated $6.15M sold.

Jane Street first reported a position in RLAY in Q1 2021 and held it in 17 quarters. The position peaked at $4.21M in Q1 2026. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Jane Street reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 423,536 Relay Therapeutics shares in Q2 2026, an estimated $6.15M.
  • Jane Street first reported a position in Relay Therapeutics in Q1 2021 and held it in 17 quarters.
  • Jane Street's Relay Therapeutics position peaked at $4.21M in Q1 2026.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.